Skip to main content
MedCap AB (publ) (STO:MCAP)
Sweden flag Sweden · Delayed Price · Currency is SEK
443.00
-14.00 (-3.06%)
May 13, 2025, 5:29 PM CET

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21
Medtech Revenue (Pre-Q3 2023 Reporting)
Log In
Log In
Log In
Log In
Medtech Revenue (Pre-Q3 2023 Reporting) Growth
Log In
Log In
Log In
Log In
Specialty Pharma
Log In
Log In
Log In
Log In
Specialty Pharma Growth
Log In
Log In
Log In
Log In
Assistive Tech
Log In
Log In
Log In
Log In
Assistive Tech Growth
Log In
Log In
Log In
Log In
Medtech Revenue (Post-Q2 2023 Reporting)
Log In
Log In
Log In
Log In
Medtech Revenue (Post-Q2 2023 Reporting) Growth
Log In
Log In
Log In
Log In
Pharmaceuticals
Log In
Log In
Log In
Log In
Pharmaceuticals Growth
Log In
Log In
Log In
Log In
Assistive Technology
Log In
Log In
Log In
Log In
Assistive Technology Growth
Log In
Log In
Log In
Log In
Medical Devices
Log In
Log In
Log In
Log In
Medical Devices Growth
Log In
Log In
Log In
Log In
Nutrition & Other Food
Log In
Log In
Log In
Log In
Nutrition & Other Food Growth
Log In
Log In
Log In
Log In
Other Product
Log In
Log In
Log In
Log In
Other Product Growth
Log In
Log In
Log In
Log In

EBIT by Product

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21
Medtech Operating Profit (Pre-Q3 2023 Reporting)
Log In
Log In
Log In
Log In
Medtech Operating Profit (Pre-Q3 2023 Reporting) Growth
Log In
Log In
Log In
Log In
Specialty Pharma Operating Profit
Log In
Log In
Log In
Log In
Specialty Pharma Operating Profit Growth
Log In
Log In
Log In
Log In
Other and Eliminations from Operating Profit
Log In
Log In
Log In
Log In
Other and Eliminations from Operating Profit Growth
Log In
Log In
Log In
Log In
Assistive Tech Operating Profit
Log In
Log In
Log In
Log In
Assistive Tech Operating Profit Growth
Log In
Log In
Log In
Log In
Medtech Operating Profit (Post-Q2 2023 Reporting)
Log In
Log In
Log In
Log In
Medtech Operating Profit (Post-Q2 2023 Reporting) Growth
Log In
Log In
Log In
Log In

EBITDA by Product

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21
Medtech Adjusted EBITDA (Pre-Q3 2023 Reporting)
Log In
Log In
Log In
Log In
Medtech Adjusted EBITDA (Pre-Q3 2023 Reporting) Growth
Log In
Log In
Log In
Log In
Specialty Pharma Adjusted EBITDA
Log In
Log In
Log In
Log In
Specialty Pharma Adjusted EBITDA Growth
Log In
Log In
Log In
Log In
Other and Eliminations from Adjusted EBITDA
Log In
Log In
Log In
Log In
Other and Eliminations from Adjusted EBITDA Growth
Log In
Log In
Log In
Log In
Assistive Tech Adjusted EBITDA
Log In
Log In
Log In
Log In
Assistive Tech Adjusted EBITDA Growth
Log In
Log In
Log In
Log In
Medtech Adjusted EBITDA (Post-Q2 2023 Reporting)
Log In
Log In
Log In
Log In
Medtech Adjusted EBITDA (Post-Q2 2023 Reporting) Growth
Log In
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21
Sweden
Log In
Log In
Log In
Log In
Sweden Growth
Log In
Log In
Log In
Log In
Nordic (ex-Sweden)
Log In
Log In
Log In
Log In
Nordic (ex-Sweden) Growth
Log In
Log In
Log In
Log In
Europe (ex-Nordic)
Log In
Log In
Log In
Log In
Europe (ex-Nordic) Growth
Log In
Log In
Log In
Log In
Rest of the World
Log In
Log In
Log In
Log In
Rest of the World Growth
Log In
Log In
Log In
Log In